New Social Security Ruling on Sickle Cell Disease

Sickle cell anemia, a condition in which there aren’t enough healthy red blood cells to adequately carry oxygen throughout your body, is a rare and likely debilitating disease.  Although life expectancy has dramatically increased for patients with sickle cell over the last 40 years, there is still no reliable and practical cure.  Treatment is focused on symptom management.

Recently, SSA issued Social Security Ruling (SSR) 17-3p which provides guidance on how SSA decision makers should consider evidence related to Sickle cell.  First, SSR 17-3p lays out the most common variants of Sickle cell disease (SCD), describing the general severities for each.  SSA states that since people with SCD trait “rarely have signs and symptoms associated with SCD and usually do not need treatment” the diagnosis of SCD alone is not an impairment without other medical findings.  The new ruling then reiterates the requirements for a proper diagnosis.

Finally, SSR 17-3p explains how SCD is evaluated when assessing the level of impact (severity) on your ability to function.  Essentially, SSA will consider all evidence, including the impact of treatment, to determine if you are unable to work.

Read more here:

Viner Disability Law can help.  If you suffer from SCD, our experienced attorneys will review your case and determine if SSR 17-3p provides a basis for a favorable decision.  Call now at (720) 515-9012 for a free consultation.